These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


677 related items for PubMed ID: 12845224

  • 1. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
    Bondanelli M, Ambrosio MR, Margutti A, Franceschetti P, Zatelli MC, degli Uberti EC.
    Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
    [Abstract] [Full Text] [Related]

  • 2. Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man.
    degli Uberti EC, Ambrosio MR, Cella SG, Margutti AR, Trasforini G, Rigamonti AE, Petrone E, Müller EE.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2885-8. PubMed ID: 9284714
    [Abstract] [Full Text] [Related]

  • 3. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation.
    Bondanelli M, Ambrosio MR, Margutti A, Boldrini P, Basaglia N, Franceschetti P, Zatelli MC, Degli Uberti EC.
    Metabolism; 2002 Oct; 51(10):1363-9. PubMed ID: 12370860
    [Abstract] [Full Text] [Related]

  • 4. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
    Torronteras R, Gracia-Navarro F, Elsaesser F.
    Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
    [Abstract] [Full Text] [Related]

  • 5. Aromatized Estrogens Amplify Nocturnal Growth Hormone Secretion in Testosterone-Replaced Older Hypogonadal Men.
    Roelfsema F, Yang RJ, Takahashi PY, Erickson D, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2018 Dec 01; 103(12):4419-4427. PubMed ID: 30032193
    [Abstract] [Full Text] [Related]

  • 6. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
    Jaffe CA, Turgeon DK, Friberg RD, Watkins PB, Barkan AL.
    J Clin Endocrinol Metab; 1995 Nov 01; 80(11):3321-6. PubMed ID: 7593445
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M, Bossoni S, Alí A, Doga M, Reimondo G, Milani G, Peretti P, Manelli F, Angeli A, Giustina A.
    J Clin Endocrinol Metab; 2000 Mar 01; 85(3):1310-5. PubMed ID: 10720081
    [Abstract] [Full Text] [Related]

  • 8. Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism.
    Del Rio G, Carani C, Velardo A, Zizzo G, Procopio M, Coletta F, Marrama P, Ghigo E.
    J Endocrinol Invest; 1995 Oct 01; 18(9):690-5. PubMed ID: 8719299
    [Abstract] [Full Text] [Related]

  • 9. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L, Maccario M, Lanfranco F, Ramunni J, Di Vito L, Grottoli S, Muller EE, Ghigo E, Arvat E.
    J Clin Endocrinol Metab; 2000 Oct 01; 85(10):3604-8. PubMed ID: 11061509
    [Abstract] [Full Text] [Related]

  • 10. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M, Frohman LA.
    J Clin Endocrinol Metab; 1990 Jul 01; 71(1):157-63. PubMed ID: 1973420
    [Abstract] [Full Text] [Related]

  • 11. Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
    Park S, Peng XD, Frohman LA, Kineman RD.
    Neuroendocrinology; 2005 Jul 01; 81(6):360-71. PubMed ID: 16244497
    [Abstract] [Full Text] [Related]

  • 12. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD.
    Eur J Endocrinol; 1998 Jul 01; 139(1):59-71. PubMed ID: 9703380
    [Abstract] [Full Text] [Related]

  • 13. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD, Keenan DM, Bailey JN, Miles JM, Bowers CY.
    Eur J Endocrinol; 2009 Aug 01; 161(2):293-300. PubMed ID: 19458139
    [Abstract] [Full Text] [Related]

  • 14. Mutual priming effects of GHRH and arginine on GH secretion: informative procedure for evaluating GH secretory dynamics.
    Sato T, Igarashi N, Miyagawa K, Shimizu M, Nishikawa T, Hashimoto T.
    Endocrinol Jpn; 1990 Aug 01; 37(4):501-9. PubMed ID: 1982090
    [Abstract] [Full Text] [Related]

  • 15. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M, Günther T, von zur Mühlen A, Brabant G.
    Clin Endocrinol (Oxf); 1992 Sep 01; 37(3):233-9. PubMed ID: 1358484
    [Abstract] [Full Text] [Related]

  • 16. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S, Corcoran C, Stanley T, Katznelson L, Klibanski A.
    J Clin Endocrinol Metab; 1998 Dec 01; 83(12):4251-6. PubMed ID: 9851759
    [Abstract] [Full Text] [Related]

  • 17. Acute hyperglycemia and activation of the beta-adrenergic system exhibit synergistic inhibitory actions on growth hormone (GH) releasing hormone-induced GH release.
    Park C, Yang I, Woo J, Kim S, Kim J, Kim Y, Park S.
    Eur J Endocrinol; 2003 Jun 01; 148(6):635-40. PubMed ID: 12773135
    [Abstract] [Full Text] [Related]

  • 18. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
    Eakman GD, Dallas JS, Ponder SW, Keenan BS.
    J Clin Endocrinol Metab; 1996 Mar 01; 81(3):1217-23. PubMed ID: 8772602
    [Abstract] [Full Text] [Related]

  • 19. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.
    Bertherat J, Timsit J, Bluet-Pajot MT, Mercadier JJ, Gourdji D, Kordon C, Epelbaum J.
    J Clin Invest; 1993 Apr 01; 91(4):1783-91. PubMed ID: 8097209
    [Abstract] [Full Text] [Related]

  • 20. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep.
    Magnan E, Cataldi M, Guillaume V, Mazzocchi L, Dutour A, Razafindraibe H, Sauze N, Renard M, Oliver C.
    Endocrinology; 1994 Feb 01; 134(2):562-7. PubMed ID: 7905408
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.